Centiva Capital »

Amylyx Pharmaceuticals shares owned by Centiva Capital

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Centiva Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $282k 19k 14.72

More positions owned by Centiva Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr National Mun Etf (MUB)
Ishares Tr 1 3 Yr Treas Bd Call Option (SHY)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
stock
Simon Property Call Option (SPG)
Agnc Invt Corp Com reit Call Option (AGNC)
Advanced Micro Devices (AMD)
Citigroup Com New Call Option (C)

View all positions for Centiva Capital

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Jupiter Asset Management
Marshall Wace
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft

View all funds holding Amylyx Pharmaceuticals